Bicycle Therapeutics Statistics
Total Valuation
BCYC has a market cap or net worth of $324.62 million. The enterprise value is -$218.12 million.
Important Dates
The last earnings date was Thursday, April 30, 2026, before market open.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BCYC has 69.81 million shares outstanding. The number of shares has increased by 6.99% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 69.81M |
| Shares Change (YoY) | +6.99% |
| Shares Change (QoQ) | +0.46% |
| Owned by Insiders (%) | 1.80% |
| Owned by Institutions (%) | 39.29% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.13 |
| Forward PS | n/a |
| PB Ratio | 0.59 |
| P/TBV Ratio | 0.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.66, with a Debt / Equity ratio of 0.03.
| Current Ratio | 12.66 |
| Quick Ratio | 12.28 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,173.12 |
Financial Efficiency
Return on equity (ROE) is -33.84% and return on invested capital (ROIC) is -22.58%.
| Return on Equity (ROE) | -33.84% |
| Return on Assets (ROA) | -19.38% |
| Return on Invested Capital (ROIC) | -22.58% |
| Return on Capital Employed (ROCE) | -39.46% |
| Weighted Average Cost of Capital (WACC) | 12.32% |
| Revenue Per Employee | $220,472 |
| Profits Per Employee | -$760,524 |
| Employee Count | 288 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BCYC has paid $1.41 million in taxes.
| Income Tax | 1.41M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.84% in the last 52 weeks. The beta is 1.56, so BCYC's price volatility has been higher than the market average.
| Beta (5Y) | 1.56 |
| 52-Week Price Change | -41.84% |
| 50-Day Moving Average | 4.76 |
| 200-Day Moving Average | 6.32 |
| Relative Strength Index (RSI) | 48.98 |
| Average Volume (20 Days) | 340,123 |
Short Selling Information
The latest short interest is 2.70 million, so 6.95% of the outstanding shares have been sold short.
| Short Interest | 2.70M |
| Short Previous Month | 2.93M |
| Short % of Shares Out | 6.95% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.12 |
Income Statement
In the last 12 months, BCYC had revenue of $63.50 million and -$219.03 million in losses. Loss per share was -$3.16.
| Revenue | 63.50M |
| Gross Profit | -155.27M |
| Operating Income | -238.14M |
| Pretax Income | -217.62M |
| Net Income | -219.03M |
| EBITDA | -232.23M |
| EBIT | -238.14M |
| Loss Per Share | -$3.16 |
Full Income StatementBalance Sheet
The company has $559.47 million in cash and $15.34 million in debt, with a net cash position of $544.14 million or $7.79 per share.
| Cash & Cash Equivalents | 559.47M |
| Total Debt | 15.34M |
| Net Cash | 544.14M |
| Net Cash Per Share | $7.79 |
| Equity (Book Value) | 554.32M |
| Book Value Per Share | 7.95 |
| Working Capital | 570.25M |
Full Balance SheetCash Flow
| Operating Cash Flow | -229.23M |
| Capital Expenditures | -2.46M |
| Depreciation & Amortization | 6.39M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | -244.54% |
| Operating Margin | -375.05% |
| Pretax Margin | -342.73% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BCYC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.99% |
| Shareholder Yield | -6.99% |
| Earnings Yield | -67.18% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for BCYC is $12.11, which is 160.43% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.11 |
| Price Target Difference | 160.43% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 36.54% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BCYC has an Altman Z-Score of 0.92 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.92 |
| Piotroski F-Score | 2 |
